Search Results - "Skelsey, Maral K"

Patients’ willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer by Boeri, Marco, Skelsey, Maral K., Schiro, James A., Dozier, Susan E., Glinert, Robert, Okun, Martin M.

“…BACKGROUNDNon-immunosuppressed patients with a history of multiple non-melanoma skin cancers (NMSCs) taking oral nicotinamide supplementation experienced a 23%…”
Get full text

Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions by Ferris, Laura K, Gerami, Pedram, Skelsey, Maral K, Peck, Gary, Hren, Catherine, Gorman, Christopher, Frumento, Tana, Siegel, Daniel M

“…About 3 million surgical pigmented skin lesion biopsies are performed each year in the USA alone to diagnose fewer than 200 000 new cases of invasive melanoma…”
Get full text

Response to Marchetti et al by Rigel, Darrell S, Whitaker, John W, Skelsey, Maral K, Peck, Gary, Howell, Michael D, Jansen, Burkhard

Get full text

Clinical Performance of a Noninvasive Melanoma Rule-Out Test Across Fitzpatrick Skin Types by Skelsey, Maral K., Loftis, Brent, Kaufmann, Mark D., Siegel, Daniel M., Bhatia, Neal, Wangia, Michael, Walker, Michael, Rigby, Andrew, Whitaker, John W., Stone, Steven, Moccia, Mary, O’Brien, Kaleigh A., Jansen, Burkhard, Clarke, Loren E.

Get full text

Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry Study by Brouha, Brook, Ferris, Laura K, Skelsey, Maral K, Peck, Gary, Moy, Ronald, Yao, Zuxu, Jansen, Burkhard

Get more information

Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study by Ferris, Laura K, Rigel, Darrell S, Siegel, Daniel M, Skelsey, Maral K, Peck, Gary L, Hren, Catherine, Gorman, Christopher, Frumento, Tana, Jansen, Burkhard, Yao, Zuxu, Rock, Jim, Knezevich, Stevan R, Cockerell, Clay J

“…The revised version of the article corrected Figure 2. This change appears in the revised online PDF copy of this article…”
Get full text

15335 Real-world utility of a noninvasive gene expression test to rule out primary cutaneous melanoma: A large US registry study by Brouha, Brook, Ferris, Laura K., Skelsey, Maral K., Peck, Gary, Yao, Zuxu, Jansen, Burkhard

Get full text

Real-World Performance of a Noninvasive Cutaneous Melanoma Rule-Out Test: A Multicenter U.S. Registry Study by Kaufmann, Mark, Skelsey, Maral, Ferris, Laura, Walker, Michael, Rigby, Andrew, Jansen, Burkhard, Clarke, Loren

“…Introduction: Non-invasive adjuncts to visual assessment of pigmented lesions may reduce biopsies of benign lesions without compromising melanoma detection. A…”
Get full text

Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study by Ferris, Laura K, Rigel, Darrell S, Siegel, Daniel M, Skelsey, Maral K, Peck, Gary L, Hren, Catherine, Gorman, Christopher, Frumento, Tana, Jansen, Burkhard, Yao, Zuxu, Rock, Jim, Knezevich, Stevan R, Cockerell, Clay J

“…The Pigmented Lesion Assay (PLA, sensitivity 91-95%, specificity 69-91%, negative predictive value ?99%) is a commercially available, non-invasive gene…”
Get full text